Neonatal group B streptococcal sepsis: prevention worthwhile?

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1309, 2001-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neonatal group B streptococcal sepsis prevention worthwhile

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 334, 2001-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Regionalisation of subarachnoid haemorrhage care worthwhile?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 456, 2004-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Dyspepsia: which non-invasive management strategy worthwhile?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 385, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Preventing group B streptococcal disease: which strategy best?

Inpharma, Vol. 1, Iss. 1501, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Patient education during H. pylori eradication therapy worthwhile?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 362, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite